logo-loader

Deltex Medical Group plc

Receive alerts
Market:
AIM
Market Cap:
£5.83 m
Price
1.13 GBX
Change
4.65%
52 weeks high
2.08
52 weeks low
0.85

In brief

Deltex Medical manufactures and markets CardioQ-ODM™ Oesophageal Doppler Monitoring (ODM) systems. ODM is the only therapy to measure blood flow in the central circulation in real time. Minimally invasive, easy to set up and quick to focus, the technology generates a low-frequency ultrasound signal, which is highly sensitive to changes in flow and measures them immediately. Randomised Controlled Trials (RCTs), using Doppler, have demonstrated that early fluid management intervention can reduce postoperative complications, reduce intensive care admissions and reduce the length of hospital stay.

Latest

RNS

Finance Director Appointed

1 day, 16 hours ago
RNS

Exercise of Options

1 week, 1 day ago
RNS

Exercise of Options

on 18/10/19
RNS

Directorate Change

on 7/10/19
RNS

Interim Results

on 23/9/19